Globe Roche Logo

Transforming Testing & Treatment Together

Giving you confidence in the performance of our systems and assays in your laboratory

cobas® 8800 System

Our commitment to quality

As pioneers of polymerase chain reaction (PCR) technology, we continue to demonstrate our commitment to scientific and clinical excellence. Roche systems and assays are the trusted choice in clinical trials across the industry—from plasma and blood screening and viral load testing to more recent leadership with HPV Primary Screening and advances in oncology testing with the cobas® EGFR Mutation Test v2. We hold our products to the highest performance standards to give you confidence in every result.

Advanced assay design

Our unrivaled investment in research and development allows us to stay ahead of constantly evolving diseases, lets you inform the best possible treatment decisions, and ensures we can keep the blood supply safe for all. Through an unrelenting dedication to innovation, Roche consistently delivers industry leading breakthroughs:

Test Tubes
Pioneered the dual target approach for HIV-1 viral load monitoring
Developed the only clinically validated, FDA-approved and CE-marked assay for first-line, primary screening of cervical cancer
Detect EGFR Mutations
Our cobas® EGFR v2 test allows you to detect EGFR mutations in plasma and FFPE tissue to determine mutation status
Blood Pouch
Real-time detection and discrimination of HIV, HCV, and HBV in a single test for blood donor screening

Ensuring confidence in results

Results generated on Roche systems are proven to be standardised and comparable across all platforms.1* The performance of new assays is verified with high precision across platforms for accuracy and traceability according to World Health Organization (WHO) standards.

Standardised results across platforms1*
*Standardised for HIV-1, HBV and HCV.1

Personalised solutions for your specific needs

Working closely with our partners helps to strengthen our relationship and understanding of what solutions you need today and may need in the future.

We offer a broad range of molecular IVD and LDT solutions to suit your specific needs
Standalone instruments or decentralised testing
cobas® Liat® System & MagNA Pure 24 System
Systems offering traceability and maximum flexibility
cobas® 4800 System & cobas® 6800 System
Centralised molecular
cobas® 8800 System, MagNA Pure 96 System & cobas® 4800 System

Comprehensive solutions to meet your molecular testing needs

Our wide array of systems for IVD testing offer a range of throughputs, and enable different configurations.

cobas® Liat® System
cobas® Liat® System runs on-demand tests for a single sample and is ideal for point-of-care settings or anywhere a rapid test result is needed
cobas® 4800 System is a flexible solution that offers high efficiency and walk-away sample preparation
cobas® 6800/8800 Systems
cobas® 6800/8800 Systems offer high automation and throughput and a consolidated testing platform for IVD and LDTs**

Our broad assay menu offers solutions for any throughput or molecular testing requirement.

**IVD and LDT samples are run on separate processing plates.
Learn More
Roche Laboratory Developed Testing (LDT) solutions provide flexible options for variable lab throughputs: from stand-alone systems to highly automated solutions.

MagNA Pure 24 System
MagNA Pure 24 System is a fully automated clinical nucleic acid extraction system that brings you walkaway automation, designed to minimise user intervention and extraction-to-extraction variability.
The FLOW Solution handles automates complex testing menu bringing traceability and scalability to your LDTs.
LightCycler® 480 System
LightCycler® 480 System offers speed, accuracy and versatility for real-time PCR applications in research.

Our diverse offering of nucleic acid purification and qPCR solutions enable you to expand, customise, and standardise your lab's LDT portfolio.

FLOW Solution is for general laboratory use. Not available in the U.S.
Learn More

Automation & IT in Molecular Diagnostic Testing

Experience a new paradigm in workflow efficiency. Roche pre- and post-analytic solutions enable personalised laboratory automation with cross-disciplinary connectivity.

Read more
Colleagues shaking hands

Workflow and technical consulting

Our experts are specialised, local, and at your service to help you optimise your workflow and processes with the right technology for your future laboratory needs. Based on your key performance criteria—financial, clinical, quality or personnel—we can work with you to improve turnaround time (TAT), reduce errors, and create a more efficient use of your space and manpower.

Premium service & support

Premium service & support

Our team of national, regional, and international application specialists are there when you need them, providing timely technical advice to help you get the most out of your tests and systems. In situations where your equipment might require support, we have a large on-the-ground force to ensure nothing gets in the way of your testing. Roche has more engineers and service personnel than any other diagnostic provider, so you don't have to wait for days until you get the help you need.

Invest in innovation

Invest in innovation

When you choose a solution from Roche, you're securing your future. We invest heavily into molecular diagnostics—in new assays, instruments (systems), and enhancements and through internal developments and external acquisitions. We stand behind every product and service, and want to ensure the solution that you choose delivers a top-quality experience and fosters a long-term partnership.

Our commitment to excellence, corporate stability, and delivery of innovation makes Roche the ideal choice for the future of your lab. You can be confident that our products and applications will continue to be supported into the future, and that we will adapt as your needs change.

Learn more


  1. Performance evaluation of the new real-time PCR-based COBAS® HCV assay for use on the COBAS 6800/8800 systems for the detection and quantification of HCV RNA - RING Study. Poster presented at AASLD, Nov 11-14, 2016, Boston, MA, USA.
  2. Iordanoaia N, et al. Cross-contamination compliance of cobas p 612 pre-analytical system in use with cobas® 6800/8800 Systems. Declaration of Serology and NAT testing compliance. Poster presented at ISBT, Dubai, UAE, 2016 September.